These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Shepard JD, Chuang DT, Shaham Y, Morales M. Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063 [Abstract] [Full Text] [Related]
3. Decreased tyrosine hydroxylase mRNA but not cholecystokinin mRNA in the pars compacta of the substantia nigra and ventral tegmental area of aged rats. Schuligoi R, Fernandez J, Heavens RP, Sirinathsinghji DJ. Brain Res Mol Brain Res; 1993 Sep; 19(4):333-8. PubMed ID: 7901729 [Abstract] [Full Text] [Related]
7. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Zhang Y, Loonam TM, Noailles PA, Angulo JA. Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542 [Abstract] [Full Text] [Related]
8. Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons. Du Y, Lee YB, Graves SM. Neuropharmacology; 2021 Dec 01; 200():108817. PubMed ID: 34610287 [Abstract] [Full Text] [Related]
9. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons. Munhall AC, Wu YN, Belknap JK, Meshul CK, Johnson SW. Neurotoxicology; 2012 Jun 01; 33(3):429-35. PubMed ID: 22521663 [Abstract] [Full Text] [Related]
10. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. Sarabi A, Hoffer BJ, Olson L, Morales M. J Comp Neurol; 2001 Dec 10; 441(2):106-17. PubMed ID: 11745638 [Abstract] [Full Text] [Related]
11. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons. Weiss-Wunder LT, Chesselet MF. Neuroscience; 1992 Jul 10; 49(2):297-305. PubMed ID: 1359452 [Abstract] [Full Text] [Related]
13. Alterations of calmodulin and its mRNA in rat brain after acute and chronic administration of methamphetamine. Shimizu Y, Akiyama K, Kodama M, Ishihara T, Hamamura T, Kuroda S. Brain Res; 1997 Aug 15; 765(2):247-58. PubMed ID: 9313897 [Abstract] [Full Text] [Related]
16. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. Kousik SM, Carvey PM, Napier TC. Eur J Neurosci; 2014 Aug 15; 40(4):2707-14. PubMed ID: 24890790 [Abstract] [Full Text] [Related]
17. Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. Wang HL, Morales M. J Comp Neurol; 2008 Jul 20; 509(3):302-18. PubMed ID: 18478589 [Abstract] [Full Text] [Related]
18. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Harvey DC, Laćan G, Melegan WP. Exp Brain Res; 2000 Aug 20; 133(3):349-58. PubMed ID: 10958525 [Abstract] [Full Text] [Related]
19. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Liu B, Traini R, Killinger B, Schneider B, Moszczynska A. Exp Neurol; 2013 Sep 20; 247():359-72. PubMed ID: 23313192 [Abstract] [Full Text] [Related]
20. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study. Tajiri K, Emori K, Murata M, Tanaka K, Suzuki M, Uehara T, Sumiyoshi T, Ashby CR, Kurachi M. Synapse; 2001 Jun 15; 40(4):275-81. PubMed ID: 11309843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]